Riegel v. Medtronic, Inc.

From Wikipedia, the free encyclopedia
  (Redirected from Riegel v. Medtronic, Inc)
Jump to: navigation, search
Riegel v. Medtronic, Inc.
Seal of the United States Supreme Court.svg
Argued December 4, 2007
Decided February 20, 2008
Full case name Charles R. Riegel, et ux. v. Medtronic, Inc.
Docket nos. 06-179
Citations 552 U.S. 312 (more)
Argument Oral argument
Holding
The MDA’s pre-emption clause bars common-law claims challenging the safety or effectiveness of a medical device marketed in a form that received premarket approval from the FDA.
Court membership
Case opinions
Majority Scalia, joined by Roberts, Stevens, Kennedy, Souter, Thomas, Breyer, Alito
Dissent Ginsburg

Riegel v. Medtronic, Inc., 552 U.S. 312 (2008), is a United States Supreme Court case in which the Court held that the pre-emption clause of the Medical Device Amendment bars state common-law claims that challenges the effectiveness or safety of a medical device marketed in a form that received premarket approval from the Food and Drug Administration.

It modified the rule in Medtronic, Inc. v. Lohr, 518 U.S. 470 (1996).

See also[edit]

Further reading[edit]